Shell Asset Management’s Sciclone Pharmaceuticals SCLN Stock Holding History
Bought
Maintained
Sold
Other funds holding SCLN
Shell Asset Management's SCLN Position: Q1 2016 in Review
Shell Asset Management sold out of Sciclone Pharmaceuticals (SCLN) in Q1 2016, closing a stake of 102,502 shares — an estimated $943K sold.
Shell Asset Management first reported a position in SCLN in Q2 2014 and held it in 7 quarters. The position peaked at $1.02M in Q2 2015. 143 funds tracked by Wall St. Rank hold SCLN as of Q1 2016.
- Shell Asset Management reported no remaining Sciclone Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
- Shell Asset Management sold 102,502 Sciclone Pharmaceuticals shares in Q1 2016, an estimated $943K.
- Shell Asset Management first reported a position in Sciclone Pharmaceuticals in Q2 2014 and held it in 7 quarters.
- Shell Asset Management's Sciclone Pharmaceuticals position peaked at $1.02M in Q2 2015.
- 143 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals as of Q1 2016.
Based on Shell Asset Management's 13F filing for Q1 2016, filed 11 May 2016.